The Patent Trial and Appeal Board invalidated a RainDance Technologies patent earlier this week for obviousness. The patent, which covers a method for manipulating the size of liquid droplets used in microfluidic diagnostic tests, was challenged by manufacturer 10X Genomics Inc.
The panel, after conducting an inter partes review, found that the technique’s characteristics, which RainDance argued distinguish its technology from similar inventions, are obvious and that a reasonably trained scientist could infer and apply them on their own.
Get the full story at our sister site, Drug Delivery Business News.
The post Patent board invalidates RainDance patent for obviousness appeared first on MassDevice.
from MassDevice http://ift.tt/2jHqOqD
Cap comentari:
Publica un comentari a l'entrada